Through the Microscope: Examining Modern Medicine

February 21, 2017

Medical breakthroughs, including new drug therapies and health technologies, have accelerated in recent years to transform patient care, turning formerly fatal diseases into chronic ones. These innovations are treating some of the rarest diseases and are bringing new tools to doctors and care providers.

The Atlantic explored the state of modern medicine and the science that has revolutionized treatments. We examined the role of personalized medicine and how new treatments can be made accessible to patients.

Watch full session videos

To view photos from this event, please visit our Facebook page

For more information, please contact Grace Harvey at

Presented by

Atlantic Live


  • Laurie Glimcher, MD
    Laurie Glimcher, MD President and CEO Dana-Farber Cancer Institute
  • Stephen J. Ubl*
    Stephen J. Ubl* President and CEO Pharmaceutical Research and Manufacturers of America
  • Tony Coles, MD
    Tony Coles, MD Chairman and CEO Yumanity Therapeutics
  • Gilmore O'Neill, MD
    Gilmore O'Neill, MD Senior Vice President, Late Stage Clinical Development Biogen Inc.
  • Noubar Afeyan, PhD
    Noubar Afeyan, PhD Founder, CEO and Senior Managing Partner Flagship Pioneering
  • Stephen Elledge, PhD
    Stephen Elledge, PhD Gregor Mendel Professor of Genetics and Medicine Harvard Medical School and the Division of Genetics at Brigham & Women’s Hospital
  • Dan Skovronsky, MD, PhD
    Dan Skovronsky, MD, PhD Senior Vice President, Clinical and Product Development Eli Lilly and Company
  • Joie Chen
    Joie Chen Contributor AtlanticLIVE
  • Ross Andersen
    Ross Andersen The Atlantic Senior Editor
  • Robert Green, MD, MPH
    Robert Green, MD, MPH Associate Physician, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School and Director, Genomes2People Research Program
  • Lauren Stetson
    Lauren Stetson Participant of BabySeq Project
  • Joe Shortsleeve*
    Joe Shortsleeve* Former Chief Correspondent for WBZ-TV, Current Senior Advisor at Liberty Square
  • Julie Wolf-Rodda
    Julie Wolf-Rodda Director of Development Foundation for the National Institutes of Health


  • Tuesday, February 21
  • 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
  • 8:35 a.m.The DNA of Modern MedicineLaurie Glimcher, President and CEO, Dana-Farber Cancer Institute
    With Joie Chen, Contributor, AtlanticLIVE
  • 8:55 a.m.On the Frontlines of ScienceStephen Elledge, Gregor Mendel Professor of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women’s Hospital
    Julie Wolf-Rodda, Director of Development, Foundation for the National Institutes of Health
    Daniel Skovronsky, Senior Vice President, Clinical and Product Development, Eli Lilly and Company
    With Ross Andersen, Senior Editor, The Atlantic
  • 9:35 a.m.Funding the Future Noubar Afeyan, CEO, Flagship Pioneering
    Tony Coles, CEO, Yumanity Therapeutics
    Gilmore O’Neill, Senior Vice President, Late Stage Clinical Development, Biogen
    With Joie Chen, AtlanticLIVE
  • 10:05 a.m.Making Medicine PersonalRobert Green, Co-Director, BabySeq Project, Brigham and Women’s Hospital and Harvard Medical School
    Lauren Stetson, Participant in BabySeq Project
    With Ross Andersen, The Atlantic
  • 10:35 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE


Also in This Series

Upcoming Events

  • Health Care

    The Big Story: How the Virus Won

    Atlantic staff writer Ed Yong has spoken with more than 100 experts since the early stages of the pandemic.

  • Thrive: The Children's Summit

    The children of today are facing a challenging world, one that is complicated by technology and threatened by forces outside their control.

  • The Atlantic Festival

    Expect to be challenged. Expect to be entertained. Expect the unexpected.